Contract 75A50118D00014
Aktivax, Inc. · Department Of Health And Human Services · September 1, 2021
Aktivax, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 1, 2021 for $5.25 million of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on September 30, 2021. If all options are exercised, the contract could reach $38.07 million.
Contract details
- PIID
- 75A50118D00014
- Award type
- —
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 1, 2021
- Latest action
- September 30, 2021
Description
PROVIDE ADDITIONAL FUNDING FOR OPTION 1/CLIN0002 & EXTEND POP
Modification timeline
-
September 30, 2021Mod P00006 · Change Order$38.07M
-
September 24, 2021Mod P00005 · Change OrderPROVIDE A NO-COST EXTENSION OF OPTION 1/CLIN0002 THRU 9/30/2021$32.81M
-
September 1, 2021Mod P00004 · Other Administrative ActionADMINISTRATIVE ACTION: NO COST EXTENSION$32.81M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50118D00014?
Contract 75A50118D00014 is a federal contract awarded to Aktivax, Inc. by Department Of Health And Human Services on September 1, 2021 for $5.25 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50118D00014?
Aktivax, Inc. won contract 75A50118D00014 from Department Of Health And Human Services.
How much is contract 75A50118D00014 worth?
Contract 75A50118D00014 has obligated $5.25 million to date, with a total potential value of $38.07 million if all options are exercised.